OrganiGram OGI stock analysis and why Organigram OGI stock will continue lower

Colchicine Stumbles for Protecting the Heart From Thoracic Surgery

AMSTERDAM — Anti-inflammatory colchicine (Lodoco) given perioperatively around major non-cardiac thoracic surgery did not cut atrial fibrillation (Afib) or myocardial injury complications, the COP-AF trial

August 26, 2023

New compound ZTA-26 could be a game-changer in lipid metabolism regulation

Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders.

August 6, 2024

Talkiatry + NOCD Partner to Strengthen OCD Care Journeys

What You Should Know: NOCDand Talkiatry, today announced a partnership to offer treatment to people with OCD who need both medication management as well as

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.